JULIO EDUARDO
NUÑEZ VILLOTA
TITULAR DE UNIVERSIDAD
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (13)
2024
-
Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes
European Journal of Internal Medicine
-
Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING-HF trial
Journal of Cachexia, Sarcopenia and Muscle, Vol. 15, Núm. 2, pp. 681-689
-
Lipoprotein(a) and Long-Term Recurrent Infarction After an Acute Myocardial Infarction
American Journal of Cardiology, Vol. 211, pp. 9-16
-
Obesity and cardiovascular and renal disease. Consensus document of the Preventive Cardiology, Clinical Cardiology, and Heart Failure Associations of the Spanish Society of Cardiology
REC: CardioClinics
-
Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry
Revista espanola de cardiologia (English ed.), Vol. 77, Núm. 1, pp. 50-59
2023
-
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus
Journal of Clinical Medicine, Vol. 12, Núm. 1
-
Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin
Journal of Clinical Medicine, Vol. 12, Núm. 21
-
Identifying the patient with heart failure to be treated with vericiguat
Current Medical Research and Opinion, Vol. 39, Núm. 5, pp. 661-669
-
Optimizing the management of patients with worsening heart failure: beyond heart failure hospitalization
Expert Opinion on Pharmacotherapy, Vol. 24, Núm. 6, pp. 705-713
-
Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry
Revista Espanola de Cardiologia
-
Sex differences in Cardiorenal Syndrome: Insights from CARDIOREN Registry
Current Heart Failure Reports, Vol. 20, Núm. 3, pp. 157-167
2022
-
Individualizing the treatment of patients with heart failure with reduced ejection fraction: a journey from hospitalization to long-term outpatient care
Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 14, pp. 1589-1599
2021
-
Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice
REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48